Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dipyridamole for Restless Legs Syndrome in Uremia
NCT07199504Phase 3Recruiting
- Start
- Sep 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dipyridamole in restless legs syndrome (RLS). Started Sep 2025; status: recruiting.
02
Drugs
dipyridamole
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT07199504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07199504.